Telehealth Patient Acquisition Cost — What to Expect in 2026

Patient acquisition cost in telehealth is the most misreported number on every operator deck we see. Brands quote a single CAC figure that blends consultations with conversions, organic with paid, branded search with cold prospecting, and reactivated customers with brand-new patients. The result is a number that flatters the deck and breaks the business when you scale against it.

After managing $50M+ in telehealth paid social spend across GLP-1, TRT, ED, hair loss, and mental health brands, here is what telehealth patient acquisition cost actually looks like in 2026, how it varies by vertical, and the levers that move it.

What "Patient Acquisition Cost" Actually Means

Before quoting a number, define what you are measuring. Consultation CAC (cost per booked telehealth visit) runs 40-60% lower than paying patient CAC (cost per first prescription). Brands that quote consultation CAC as patient acquisition cost are off by 2× and will discover this when their first month of scaled spend converts at the actual ratio.

The number that matters for unit economics is fully-loaded patient acquisition cost: total marketing spend (paid media, agency fees, creative production, MarTech) divided by net new paying patients in the same window. Anything looser than this hides leaks.

2026 Patient Acquisition Cost by Vertical

GLP-1 (compounded semaglutide and tirzepatide): $180-320 fully-loaded CAC at $100-300K monthly spend. Brand-name GLP-1 is $250-400 because qualification gates push consultation-to-purchase rates down. State-restricted compounding adds $30-60 to CAC because creative cannot target high-volume restricted markets.

TRT (testosterone replacement therapy): $180-300 fully-loaded CAC. TRT CAC is structurally higher than ED because the audience deliberates longer (2-6 weeks from first ad to purchase), and lower than GLP-1 because retention and AOV are higher. Brands quoting sub-$150 TRT CAC are usually measuring consultation cost or excluding agency fees.

ED (erectile dysfunction): $70-140 fully-loaded CAC. ED is the cheapest paid acquisition in telehealth because the buyer is decisive, the script is short, and competition has already trained the market. The catch is retention — ED customers churn on $5-10 price differences, so low CAC does not automatically mean strong LTV.

Hair loss (finasteride + minoxidil): $90-170 fully-loaded CAC. Visual proof drives lower CAC, but the 4-6 month "results window" extends payback. Brands with strong before/after libraries (where compliant) consistently sit at the lower end of the range.

Mental health (anxiety, depression, ADHD): $200-400 fully-loaded CAC, with ADHD running 30-50% higher than anxiety or depression because of platform restrictions on stimulant advertising and tighter qualification gates. Mental health CAC has the widest range in telehealth because state-by-state prescriber availability creates artificial scarcity that distorts auction dynamics.

Channel-Level CAC: Where the Patients Actually Come From

Meta (Facebook + Instagram): the volume engine. Most telehealth brands acquire 60-75% of paid patients from Meta. CAC sits at or near vertical benchmark because Meta's auction is the deepest pool of cold telehealth-eligible audiences.

Google Search (non-branded): 20-40% above Meta CAC on average, but with stronger intent and higher consultation-to-purchase rates. The volume ceiling is the constraint — non-branded telehealth search rarely supports more than $30-80K monthly before CPCs spike. For comparative platform data, see Meta vs TikTok for telehealth ads.

Google Search (branded): 30-50% below Meta CAC. This is where measurement gets dangerous. Branded search captures demand that paid social created. Brands that count branded search as "low-CAC channel" without attributing the upstream Meta spend systematically misallocate budget and starve the channel that actually drives growth.

TikTok: 20-40% above Meta CAC for cold acquisition, but with a younger audience that lowers payback velocity in GLP-1 and hair loss. TikTok works best for hair loss and mental health, struggles for TRT and brand-name GLP-1.

YouTube: 40-80% above Meta CAC. Useful for retargeting and brand-building, rarely scales as a cold acquisition channel for telehealth at competitive CAC.

Affiliate and influencer: highly variable. Best programs sit 15-30% below blended Meta CAC; worst programs sit 50-100% above and quietly cannibalize organic. Treat affiliate CAC the way you treat branded search — measure incrementality, not raw attribution.

What Moves Patient Acquisition Cost Up or Down

Creative volume and quality is the single largest CAC lever. Brands producing 30-60 net new ads per month sit at benchmark CAC. Brands producing 5-10 net new ads per month sit 40-80% above benchmark because creative fatigue compounds across audiences. This is the gap most brands underestimate.

Landing page quality is the second-largest lever. A 12% landing page conversion rate vs. an 18% rate is a 33% CAC swing at constant CPC. Most telehealth brands have landing page conversion problems they read as ad problems. For diagnosis, review telehealth landing pages for paid social.

Pricing transparency moves CAC 15-30% in either direction. Showing pricing in the ad and on the landing page increases CTR and consultation cost but improves consultation-to-purchase rate enough to lower fully-loaded CAC. Hiding pricing inflates top-of-funnel metrics and breaks the conversion step.

Qualification gates (blood work, BMI thresholds, state restrictions) raise CAC by 20-50%. The lift is not always bad — brands with tighter qualification often see 2-3× higher retention, which is what actually matters for LTV-to-CAC ratios. Do not optimize CAC in isolation.

Spend level affects CAC non-linearly. From $10-50K monthly, CAC is 20-30% above benchmark due to narrow targeting and low creative volume. From $50-150K, CAC sits at benchmark. Above $300K, CAC tends to rise 10-15% as you exhaust highest-intent audiences. See scaling telehealth ad spend for the full curve.

Payback Math: When CAC Is "Good"

CAC in isolation tells you nothing. The number that matters is payback period: how many months of revenue per patient does it take to recover fully-loaded CAC? Healthy telehealth brands target 2-4 month payback. Anything above 6 months is fragile.

GLP-1 payback at $250 CAC and $300 monthly net revenue per patient is roughly 1 month, but only if 6-month retention clears 50%. The risk is not CAC — it is churn. Most GLP-1 brands that fail were paying healthy CAC against a churn rate that destroyed the cohort by month 4.

TRT payback at $240 CAC and $200 monthly net revenue is roughly 1.5 months. TRT is the most forgiving vertical because retention typically clears 70% at 6 months for properly qualified patients. A higher CAC is acceptable here because the cohort survives.

ED payback at $100 CAC and $50 monthly net revenue is 2 months, but expected retention is 3-6 months. ED is a "fast payback, fast churn" vertical — the math works only if you keep CAC genuinely below $120 and resist the temptation to scale aggressively into rising CAC. For metrics framing, review telehealth ad performance metrics that actually matter.

CAC Mistakes That Sink Telehealth Brands

Reporting blended CAC across new and returning patients. This hides the truth that new-patient CAC may be 2-3× the blended number. When you scale, only the new-patient number applies.

Excluding creative production and agency fees. Fully-loaded CAC includes them. A brand "at $180 CAC" before adding $40K of monthly creative and agency cost is actually at $220-260 CAC.

Optimizing CAC without watching retention. Lower CAC from broader targeting often degrades cohort quality enough that 3-month revenue per patient drops more than CAC. The right target is LTV-to-CAC, not CAC alone.

Treating CAC as a fixed input when planning budget. CAC moves with spend level, creative refresh cadence, seasonality, and competitor activity. Plan for a CAC band — typically benchmark ± 25% — not a point estimate.

The Operator Summary

Pick the benchmark for your vertical above. If your fully-loaded patient acquisition cost is within 15% of that range, the problem is rarely the ads — it is creative volume, landing page conversion, or qualification gating. If you are 30%+ above, you have a targeting, creative, or measurement problem that more spend will only amplify.

Do not chase CAC down at the expense of cohort quality. The telehealth brands that win in 2026 are not those with the lowest patient acquisition cost — they are the ones whose CAC, retention, and creative engine pace each other.